Organization
Parexel International GmbH
2 abstracts
Abstract
Pharmacokinetics and pharmacodynamics of proposed denosumab biosimilar and reference denosumab in healthy male subjects.Org: HEXAL AG, Parexel International GmbH,
Abstract
BASELINE IL-10 LEVELS AS A PREDICTIVE BIOMARKER FOR ACHIEVING CLINICAL RESPONSE WITH ABATACEPT IN ACPA+ PATIENTS WITH EARLY RAOrg: Bristol Myers Squibb, Parexel International GmbH, University of Leeds and Leeds NIHR Biomedical Research Centre, University of Occupational and Environmental Health, Kitakyushu, Japan, Hospital for Special Surgery,